Correlation Engine 2.0
Clear Search sequence regions

  • humans (1)
  • spinal cord (9)
  • Sizes of these terms reflect their relevance to your search.

    There is an increasing need to develop improved and non-invasive strategies to treat spinal cord injury (SCI). Nanoparticles (NPs) are an enabling technology to improve drug delivery, modulate inflammatory responses, and restore functional responses following SCI. However, the complex pathophysiology associated with SCI presents several distinct challenges that must be overcome for sufficient NP drug delivery to the spinal cord. The objective of this mini-review is to highlight the physiological challenges and cell types available for modulation and discuss several promising advancements using NPs to improve SCI treatment. We will focus our discussion on recent innovative approaches in NP drug delivery and how the implementation of multifactorial approaches to address the proinflammatory and complex immune dysfunction in SCI offers significant potential to improve outcomes in SCI.


    Atanu Chakraborty, Andrew J Ciciriello, Courtney M Dumont, Ryan M Pearson. Nanoparticle-Based Delivery to Treat Spinal Cord Injury-a Mini-review. AAPS PharmSciTech. 2021 Mar 12;22(3):101

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33712968

    View Full Text